Variables | RATE (n = 135) | RAPN (n = 224) | p-value |
---|---|---|---|
Age, median (IQR), year | 55 (47, 63) | 55 (48, 64) | 0.874 |
Gender, n (%) | 0.625 | ||
Male | 87 (64.4) | 150 (67.0) | |
Female | 48 (35.6) | 74 (33.0) | |
BMI, median (IQR), kg/m2 | 21.2 (20.1, 22.1) | 21.5 (20.5, 22.0) | 0.552 |
Symptoms at diagnosis, n (%) | 0.793 | ||
Symptomatic | 25 (18.5) | 44 (19.6) | |
Asymptomatic | 110 (81.5) | 180 (80.4) | |
Tumor side, n (%) | 0.882 | ||
Left | 71 (52.6) | 187 (52.1) | |
Right | 64 (47.4) | 172 (47.9) | |
Tumor size, median (IQR), cm | 4.8 (4.2, 5.5) | 4.5 (4.0, 5.3) | 0.178 |
ASA score ≥ 3, n (%) | 13 (9.6) | 32 (8.9) | 0.712 |
PADUA score, median (IQR) | 8 (8.0–9.0) | 8 (8.0–9.0) | 0.345 |
Preoperative eGFR, median (IQR), mL/min/1.73 m2 | 98.0 (90.0, 108.0) | 100.0 (90.5, 104.0) | 0.199 |